XM02, the First Biosimilar G-CSF, is Safe and Effective in Reducing the Duration of Severe Neutropenia and Incidence of Febrile Neutropenia in Patients with Small Cell or Non-small Cell Lung Cancer Receiving Platinum-Based Chemotherapy.
| Autor: | Gatzemeier, Ulrich, Ciuleanu, Tudor, Dediu, Mircea, Ganea-Motan, Elena, Lubenau, Heinz, Del Giglio, Auro |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; Jun2009, Vol. 4 Issue 6, p736-740, 5p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|